Syndax Pharmaceuticals, Inc.
SNDXNASDAQHealthcare● Active
$17.06
$-0.28(-1.62%)
Market Cap$1.5B
P/E Ratio—
52W High$25.59
52W Low$8.585
Syndax Pharmaceuticals, Inc.（SNDX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · SNDX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.17B | $0.02B | $0.00B | $0.00B | $0.14B |
| Cost of Revenue | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.17B | $0.02B | $0.00B | $0.00B | $0.14B |
| Gross Margin %(computed) | 95.96% | 96.51% | — | — | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.26B | $0.24B | $0.16B | $0.12B | $0.09B |
| G&A Expenses | $0.18B | $0.12B | $0.07B | $0.03B | $0.03B |
| Total Operating Expenses | $0.44B | $0.36B | $0.23B | $0.15B | $0.11B |
| Operating Income | ($0.27B) | ($0.34B) | ($0.23B) | ($0.15B) | $0.03B |
| Operating Margin %(computed) | -158.45% | — | — | — | 18.77% |
| Interest Income | $0.02B | $0.03B | $0.02B | $0.01B | $0.00B |
| Interest Expense | $0.03B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.29B) | ($0.32B) | ($0.21B) | ($0.15B) | $0.02B |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.29B) | ($0.32B) | ($0.21B) | ($0.15B) | $0.02B |
| Net Margin %(computed) | -165.60% | — | — | — | 17.84% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.29 | $-3.73 | $-2.98 | $-2.46 | $0.48 |
| Wtd Avg Shares | 0.09B | 0.09B | 0.07B | 0.06B | 0.05B |
| EBITDA | ($0.25B) | ($0.31B) | ($0.21B) | ($0.15B) | $0.03B |
| EBITDA Margin %(computed) | -146.00% | — | — | — | 19.23% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Syndax Pharmaceuticals, Inc.
关于Syndax Pharmaceuticals, Inc.（SNDX）损益表
Syndax Pharmaceuticals, Inc.（SNDX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，SNDX实现营收$0.17B，毛利润$0.17B（毛利率95.96%），净利润($0.29B)（净利率-165.60%）。
常见问题
SNDX · 4 问Syndax Pharmaceuticals, Inc.（SNDX）2025财年营收为$0.17B，同比up627.8%。
SNDX revenueSNDX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08